November 15, 2019
Community News Latest News | Tacko Fall | Bangor Metro | Franky the Pug | Today's Paper

New Chief Executive Officer announced at Bar Harbor BioTechnology

Community Author:
Post Date:
Kasey Ahlquist | BDN
Kasey Ahlquist | BDN

Bar Harbor Biotechnology is pleased to announce that Janet Yancey-Wrona, Ph.D., has accepted the position of Chief Executive Officer. Janet lives in Falmouth. She moved to Maine from Florida in 1997 when she took a job as a research scientist at IDEXX laboratories. Janet comes to Bar Harbor Biotech after several years with Maine Manufacturing LLC, a privately held producer and supplier of laboratory products for life sciences research. Prior to Maine Manufacturing, she was Chief Operating Officer of AIKO Biotechnology and was the founding President of the Maine Technology Institute. She has a BS degree in Biology from Wake Forest University, a Ph.D. degree in Biology from The University of North Carolina and performed her Postdoctoral Fellowship at the National Institute for Health in Bethesda, MD.
“Bar Harbor Biotechnology was recently restructured. A key component of that plan was to hire a new CEO focused on company growth. Bar Harbor Biotech’s Advisory Board spent a good deal of time searching for the right person to lead this company. Janet’s scientific background, combined with her management experience, brings a fresh start to Bar Harbor Biotechnology,” said John Burns, Maine Venture Fund Manager. “We look forward to the continued growth and development of Bar Harbor Biotech as it grows its existing customer base and expands into new markets.”
“I am looking forward to this opportunity to expand biotechnology here in Maine. It is exciting to be leading a business that already has a great staff and solid products with loyal customers on the market. There is a proven track record of product performance, substantiated in the scientific literature. The recent restructuring of the company allows us to now better articulate the value of working with BHB, solidify the BHB brand and grow our market presence in the field of genomics research. While I know it’s a competitive market dominated by some big names, and we will face many challenges, the support and active involvement from our advisors from the Maine Venture Fund, the Maine Technology Institute and The Jackson Laboratory gives me great confidence that we will be able to exploit the value we all believe Bar Harbor Biotechnology offers, and succeed in building a successful company. I anticipate learning a great deal while also applying all the lessons I have learned in other biotechnology businesses so that BHB can grow to its full potential. What could be more fun and rewarding?” – Janet Yancey-Wrona, Ph.D.
Bar Harbor BioTechnology was founded in 2006 in Trenton, Maine, to provide innovative software and consumables for genetics research. Among its products are the StellaARray gene expression system, GPR genetic analysis software, and XenoQ Assays that detect human tumor xenografts in mice. Bar Harbor Biotechnology was the first company spun off from The Jackson Laboratory, a Bar Harbor Maine based non-profit genetics research institution, the mission of which is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health. To learn more, visit, find their company page on LinkedIn or visit them on Facebook at